Ohta T, Saku K, Nakamura R, Maung K K, Matsuda I
Department of Pediatrics, Kumamoto University School of Medicine, Kumamoto City, Japan.
Atherosclerosis. 1998 Apr;137(2):321-8. doi: 10.1016/s0021-9150(97)00289-x.
Low plasma high density lipoprotein cholesterol (HDL-C) is a major risk factor for coronary heart disease (CHD) in adults. In the field of pediatrics, subjects with low plasma HDL-C are often found among obese or dyslipidemic children. However, it is not clear whether low HDL-C in children should be considered a risk factor for CHD. The purpose of this study was to evaluate the risk for CHD in children with low HDL-C by comparing their lipid and apolipoprotein levels and physicochemical characteristics of their HDL with those of age-matched children with normal HDL-C and CHD patients with low HDL-C. Plasma lipids and apolipoproteins were measured in 206 dyslipidemic children (dyslipidemic), 65 obese children (obese), 93 CHD patients with low HDL-C (< 40 mg/dl) and 128 children with normal HDL-C (controls). To evaluate the physicochemical characteristics of HDL, molar and fractional esterification rates of cholesterol in plasma (MER(plasma) and FER(plasma)) and HDL (MER(HDL) and FER(HDL)) were determined in 128 children with normal HDL-C, 71 dyslipidemic, 33 obese and 93 CHD who allowed second blood samples to be taken. Compared to controls, children with low HDL-C showed atherogenic profiles of lipid and apolipoprotein levels and physicochemical characteristics of HDL (lower apo A-I, lower ratio of apo A-I to apo B and higher FER(HDL)). Therefore, the differences in lipid and apolipoprotein profiles between children with low HDL-C and CHD patients with low HDL-C were examined next. The two groups of subjects based on the HDL-C level (Group I: < 30 mg/dl, Group II 30 < or = HDL-C < 40 mg/dl) were studied. Compared to CHD, Group I children showed less atherogenic apolipoprotein profiles (lower apo B and higher ratio of apo A-I to apo B). Similar findings were also found in Group II children, but the differences were less prominent than those in Group I children. FER(HDL) in children with low HDL-C were similar to those in CHD. These findings suggest that the physicochemical characteristics of HDL in children with low HDL-C are similar to those in CHD, but the abnormalities of apo B-containing lipoproteins are milder than those in CHD patients. Thus, if further changes in the nature of apo B-containing lipoproteins could be prevented, children with low HDL-C might not become high risk for CHD in later life.
低血浆高密度脂蛋白胆固醇(HDL-C)是成人冠心病(CHD)的主要危险因素。在儿科领域,血浆HDL-C水平低的情况常见于肥胖或血脂异常的儿童中。然而,儿童期HDL-C水平低是否应被视为冠心病的危险因素尚不清楚。本研究的目的是通过比较HDL-C水平低的儿童与年龄匹配的HDL-C正常儿童以及HDL-C水平低的冠心病患者的血脂、载脂蛋白水平和HDL的理化特性,来评估HDL-C水平低的儿童患冠心病的风险。对206名血脂异常儿童(血脂异常组)、65名肥胖儿童(肥胖组)、93名HDL-C水平低(<40mg/dl)的冠心病患者以及128名HDL-C水平正常的儿童(对照组)进行了血浆脂质和载脂蛋白检测。为评估HDL的理化特性,对128名HDL-C水平正常、71名血脂异常、33名肥胖以及93名同意采集第二份血样的冠心病儿童测定了血浆中胆固醇的摩尔酯化率和分数酯化率(MER(血浆)和FER(血浆))以及HDL中的胆固醇摩尔酯化率和分数酯化率(MER(HDL)和FER(HDL))。与对照组相比,HDL-C水平低的儿童在脂质和载脂蛋白水平以及HDL的理化特性方面呈现致动脉粥样硬化的特征(载脂蛋白A-I较低、载脂蛋白A-I与载脂蛋白B的比值较低以及FER(HDL)较高)。因此,接下来研究了HDL-C水平低的儿童与HDL-C水平低的冠心病患者在脂质和载脂蛋白谱方面的差异。基于HDL-C水平将两组受试者进行研究(第一组:<30mg/dl,第二组:30≤HDL-C<40mg/dl)。与冠心病患者相比,第一组儿童的载脂蛋白谱致动脉粥样硬化程度较低(载脂蛋白B较低且载脂蛋白A-I与载脂蛋白B的比值较高)。在第二组儿童中也发现了类似的结果,但差异不如第一组儿童明显。HDL-C水平低的儿童的FER(HDL)与冠心病患者相似。这些结果表明,HDL-C水平低的儿童的HDL理化特性与冠心病患者相似,但含载脂蛋白B的脂蛋白异常程度比冠心病患者轻。因此,如果能够预防含载脂蛋白B的脂蛋白性质的进一步变化,HDL-C水平低的儿童在以后的生活中可能不会成为冠心病的高危人群。